Lung Transplant Program

Below are current clinical trials.

Filter this list of studies by location, status and more.

1. Pharmacogenetics in Lung Transplant Patients

   Jacksonville, Fla.

   The purpose of this study is to:

   • Demonstrate pharmacogenetic variability in the Mayo Clinic Florida lung transplant population.
   • Describe patterns in tacrolimus levels in the context of pharmacogenomic profiles
   • Use pharmacogenomic data to establish a need for therapeutic drug monitoring in selected other drugs
   • Use pharmacogenomic data, in combination with knowledge of drug interactions, to establish sensitivity to tacrolimus dose changes

2. Mesenchymal Stem Cell Therapy for Lung Rejection

   Jacksonville, Fla.

   To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS).

3. Donor-Specific Cell Free DNA Monitoring of Thoracic Allografts

   Jacksonville, Fla., Rochester, Minn.

   The purpose of this study is to determine if DNA originating from the transplanted heart or lung can be detected in the blood and used to monitor for rejection.

4. Study Analyzing Effectiveness of BIomarker for Immunosuppression Following Induction Immunosuppression for Lung Transplantation.

   Jacksonville, Fla.

   The purpose of this study is to longitudinally follow Torque Teno Virus (TTV) levels in lung transplant recipients and attempt to find a correlation with infection or rejection events.